Our sector specialties include: Consumer; Healthcare; Power & Energy Transition; and Technology/Media. Guggenheim Equity Research analysts average 18 years of Wall Street and industry experience, bringing our clients rich perspectives and deep domain expertise.
Rigorous primary research is central to our approach. Innovation and disruption are constants in the sectors we cover and on-the-ground work keeps our team at the leading edge of trend changes for the benefit of our clients. Our signature research products uncover these findings and include:
The Consumer team covers hardline and softline retail, automotive, restaurants, and e-commerce.
The Power & Energy Transition team covers energy & industrial technology, power, and utilities.
The Healthcare team covers biotechnology, biopharmaceuticals, healthcare IT, and healthcare services.
The Technology & Media team covers software, media, and entertainment.
For access to our research offerings and products, please contact your Guggenheim Securities Sales representative or email GSInfo@guggenheimpartners.com.
Already Registered? View the content library on the research portal (login required).
I&I Spotlight Series – Treg-based Therapies
Senior Managing Directors Whitney Wolfe and Yatin Suneja partake in a Q&A session regarding the future of the Treg-Therapies.
Tech-Enabled Care Industry Overview
Head of Equity Research Craig Peckham, Healthcare IT & Services Research Analysts Sandy Draper and Jack Wallace discuss their insights on the tech-enabled care industry.
Highlights From the Second Guggenheim Targeted Protein Day
Senior Managing Director Michael Schmidt discusses the key topics from the event.
Date | Sector | Conference Name |
---|---|---|
6/20-6/23 | Healthcare | Biopharma's Next Decade Bus Tour: Views from the Top on Global Strategy and Innovation |
6/22 | Healthcare | Biopharma's Next Decade Bus Tour Reception |
Linkedin: CNBC
Michael Morris Discusses Recent Developments in Entertainment Sector
Entertainment & Digital Media Equity Research Analyst Michael Morris joins CNBC's "Squawk on the Street" to discuss recent developments and long-term outlook in the sector.
LinkedIn: Guggenheim Securities
Guggenheim Thanks Attendees and Participants of Radiopharmaceuticals Day
Guggenheim would like to thank the participants and attendees of the Guggenheim Healthcare Talks Radiopharmaceuticals Day.
LinkedIn: WSJ
Shahriar Pourreza Talks With WSJ About Investment Opportunities In Hydrogen
Senior Managing Director and Power & Utilities Equity Research Analyst Shar Pourreza, CFA spoke with Katherine Blunt at The Wall Street Journal about investment opportunities in hydrogen.
LinkedIn: Yahoo Finance
Ron Jewsikow Discusses Earnings on Yahoo Finance
Automotive Equity Research Analyst Ron Jewsikow joins Yahoo Finance to discuss recent earnings reports.
LinkedIn: Yahoo Finance
Gregory Francfort Talks Restaurants Outlook on Yahoo Finance
Restaurants Equity Research Analyst Gregory Francfort, CFA joins Yahoo Finance to discuss his outlook for restaurants.
LinkedIn: Thank You
Genomic Medicines and Rare Disease Days
Guggenheim would like to thank the participants and attendees of the Guggenheim Healthcare Talks Genomic Medicines and Rare Disease Days.
LinkedIn: Healthcare Research
Vamil Divan Launches Healthcare Stock Coverage
Vamil Divan, MD, MBA, Healthcare Equity Research Analyst covering the Global Biopharmaceutical and Biotechnology sectors, expanded Guggenheim Securities’ Healthcare Research footprint in late February by launching coverage on nine healthcare stocks.
LinkedIn: Yahoo Finance
Software Equity Research Analyst John DiFucci Discusses Takeaways From Salesforce's Earnings Call
Software Equity Research Analyst John DiFucci joins Yahoo Finance to discuss his key takeaways from Salesforce's fourth-quarter earnings call.
LinkedIn: CNBC Squawk on the Street
Software Equity Research Analyst John DiFucci Joins CNBC's Squawk on the Street
Software Equity Research Analyst John DiFucci joins CNBC’s "Squawk on the Street" to discuss his thoughts and outlook on cloud stocks.
LinkedIn: Yahoo! Finance
Gregory Francfort Discusses Subscription Services in the Restaurants Sector
Restaurants Equity Research Analyst Gregory Francfort, CFA joins Yahoo! Finance to discuss his views on subscription services in the restaurant sector.
LinkedIn: Yahoo! Finance
Why Olive Garden parent Darden Restaurants is still ‘best in class’: Analyst
Restaurants Equity Research Analyst Gregory Francfort, CFA joins Yahoo! Finance to discuss his views and outlook on the sector.
LinkedIn: CNBC Squawk Box
Software Equity Research Analyst John DiFucci Joins CNBC’s Squawk Box
Software Equity Research Analyst John DiFucci joins CNBC’s "Squawk Box" to discuss his views on the sector as well as the impact of artificial intelligence on the industry.
LinkedIn: CNBC TechCheck
Guggenheim Software Analyst John DiFucci Joins CNBC’s TechCheck
Guggenheim software analyst John DiFucci joins CNBC’s ‘TechCheck’ to discuss his software sector outlook.
LinkedIn: New York Times
Shar Pourreza Discusses Utility Industry With New York Times
Senior Managing Director Shar Pourreza, CFA spoke with The New York Times' reporter Eric Lipton on the utility industry’s outlook with the passage of the climate and economic legislation Inflation Reduction Act.
LinkedIn: CNBC Closing Bell: Overtime
Guggenheim’s Seamus Fernandez Offers His Bullish Case for Merck
Biopharmaceutical Analyst Seamus Fernandez provides insight on CNBC Closing Bell: Overtime into his recent report on MRK.
LinkedIn: Equity Research Analysts
New Duke Energy CFO Steps Into Role as Utility Considers Sale of Renewables Business
Equity Research Analyst Shar Pourreza, CFA comments on Duke Energy’s outlook and plans to manage its capital structure.
LinkedIn: I&I Spotlight Series
I&I Spotlight Series - Treg-based Therapies
Senior Healthcare Sales Specialist Whitney Wolfe interviews Biotechnology Research Analyst Yatin Suneja, covering the biotechnology sector, on the rapid innovation of Tregs for the treatment of autoimmune diseases and diseases of the nervous system.